image3
  • Home
  • About Us
    • About Evecxia
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Partnerships
    • Contact
  • Therapeutic Focus
    • Major Depression
    • CNS Disorders
  • EVX-101
    • EVX-101 Overview
    • Therapeutic Rationale
    • 5-HTP
    • Literature
  • News
  • More
    • Home
    • About Us
      • About Evecxia
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
      • Partnerships
      • Contact
    • Therapeutic Focus
      • Major Depression
      • CNS Disorders
    • EVX-101
      • EVX-101 Overview
      • Therapeutic Rationale
      • 5-HTP
      • Literature
    • News
  • Home
  • About Us
  • Therapeutic Focus
  • EVX-101
  • News

Literature

BlueCrossBlueShield_Major Depression Impact On Overall Health_Report_2018 (pdf)Download
Trivedi et al 2006_in STAR*D_SSRI Depression Outcomes (pdf)Download
Hasin et al 2018_Epidemiology of Major Depressive Disorder in The US (pdf)Download
Jacobsen et al 2016_SSRI Augmentation by 5-HTP Slow-Release (pdf)Download
Jacobsen et al 2016_Adjunctive 5-HTP Slow-Release_Review (pdf)Download
Jacobsen et al 2019_SSRI Augmentation by ORAL 5-HTP Slow-Release (pdf)Download

Copyright © 2018 EVECXIA THERAPEUTICS - All Rights Reserved.

Powered by GoDaddy Website Builder